A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.

The creatinine-to-cystatin C ratio may indicate the risk of developing amyotrophic lateral sclerosis, a large-scale database ...

News stories about clinical trials testing potential treatments were among the top 10 most-read articles on ALS News Today in ...

This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other ...

Despite the lower ALS risk, heart and metabolism problems are tied to faster disease progression and worse survival in the ...

Columnist Kristin Neva is applying something she learned about finding moments to appreciate during winter to life with ALS.

Columnist Dagmar Munn offers an explainer to highlight the deeper meaning behind the title her column, "Living Well with ALS." ...

Columnist Kristin Neva shares family memories of when her husband, Todd, had just been diagnosed when he took their son on his first ride.

People with amyotrophic lateral sclerosis (ALS) who get a feeding tube placed after loosing a lot of weight are more likely to die within a few months than those who receive feeding support before ...

Due to substantial increases in the use of healthcare resources, medical costs in the U.S. for people with amyotrophic lateral sclerosis (ALS) rise significantly as the disease progresses, going from ...